Volume 13, Issue 2 (6-2025)                   jmsthums 2025, 13(2): 15-25 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Namvar A, Asgarian F, Sohrabivafa F, Javaheri E, Pouryousef A, Abbaszadeh K, et al . Study of the epidemiologic and pathologic features of cutaneous Leishmaniasis in three endemic areas of Iran. jmsthums 2025; 13 (2) :15-25
URL: http://jms.thums.ac.ir/article-1-1362-en.html
1- Student Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran
2- Department of Laboratory Sciences, School of Paramedical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran
3- Department of Community Medicine, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran
4- Leishmaniasis Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
5- Student Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran
6- Department of Laboratory Sciences, School of Paramedical Sciences, Sabzevar University of Medical Sciences, Sabzevar, Iran
Abstract:   (11 Views)
Background & Aim: Leishmaniasis is a disease caused by the Leishmania parasite, which occurs in tropical and subtropical regions. Cutaneous leishmaniasis is the most common form of the disease in Iran. This study aimed to investigate the epidemiological and pathological characteristics of cutaneous leishmaniasis in the cities of Sabzevar, Shahroud, and Dezful.
Methods: In this cross-sectional study conducted in 2020, the medical records of all patients diagnosed with cutaneous leishmaniasis in Sabzevar, Shahroud, and Dezful were reviewed. Demographic and pathological features, including lesion type, location, number, and parasite species, were analyzed. The temporal distribution of the disease in each city was also examined. 
Results: Among the 401 affected individuals, 234 (58.3%) were men and 167 (41.7%) were women. The mean age of the patients was 28 years. The highest incidence occurred in autumn. The number of identified cases in Shahroud, Dezful, and Sabzevar was 147, 141, and 113, respectively. The majority of cases (69.6%) were from rural areas. The most common sites of lesions were the hands (55.8%) and feet (22.5%). A total of 160 patients had a single lesion, and in 151 patients (37.6%), the lesion size was approximately 2 cm.
Conclusion: Our findings indicate a high prevalence of cutaneous leishmaniasis in the three studied cities. Therefore, appropriate preventive and control measures should be implemented in these regions. Given the effectiveness of preventive strategies, comprehensive epidemiologic studies are recommended in all endemic areas of Iran. Moreover, public awareness campaigns and community participation should be strengthened to reduce the risk of transmission.
Full-Text [PDF 326 kb]   (7 Downloads)    
Type of Study: Research | Subject: Special
Received: 2024/10/21 | Accepted: 2025/02/16 | Published: 2025/11/16

References
1. de Vries HJ, Schallig HD. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. American journal of clinical dermatology. 2022;23(6):823-40. [DOI:10.1007/s40257-022-00726-8]
2. Ghazanfar M, Malik MF. Sandfly and leishmaniasis: a review. Journal of Ecosystem & Ecography. 2016;6(3). [DOI:10.4172/2157-7625.1000207]
3. Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pacific journal of tropical medicine. 2016;9(10):925-32. [DOI:10.1016/j.apjtm.2016.06.021]
4. Steverding D. The history of leishmaniasis. Parasites & vectors. 2017;10:1-10. [DOI:10.1186/s13071-017-2028-5]
5. Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the Middle East: incidence and epidemiology. PLoS neglected tropical diseases. 2014;8(10):e3208. [DOI:10.1371/journal.pntd.0003208]
6. Sabzevari S, Teshnizi SH, Shokri A, Bahrami F, Kouhestani F. Cutaneous leishmaniasis in Iran: a systematic review and meta-analysis. Microbial pathogenesis. 2021;152:104721. [DOI:10.1016/j.micpath.2020.104721]
7. Sharifi I, Khosravi A, Aflatoonian MR, Salarkia E, Bamorovat M, Karamoozian A, et al. Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan. Frontiers in Public Health. 2023;11:1091709. [DOI:10.3389/fpubh.2023.1091709]
8. Roghani AR, Yasemi MR, Jalilian M, Abdi J, Tavirani KR. Epidemiology of cutaneous leishmaniasis in Ilam province. 2013.
9. Nilforoushzadeh MA, Shirani-Bidabadi L, Hosseini SM, Fadaei-Nobari R, Jaffary F. The epidemiology of cutaneous leishmaniasis in Isfahan province, Iran, during 2001-2011. Journal of Isfahan Medical School. 2015;32(315):2241-51. [DOI:10.17795/jssc23303]
10. Barati H, Lotfi MH, Mozafari G, Dehghan H, Barati M, Tajfirouzeh A. Epidemiological aspects of cutaneous leishmaniasis in Yazd province within 2004-2013. Journal of Community Health Research. 2016;5(2):131-9.
11. Lockard RD, Wilson ME, Rodríguez NE. Sex‐related differences in immune response and symptomatic manifestations to infection with Leishmania species. Journal of immunology research. 2019;2019(1):4103819. [DOI:10.1155/2019/4103819]
12. Rostamian M, Jafari D, Abolghazi M, Farahani H, Niknam HM. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model. Parasitology research. 2018;117:2949-56. [DOI:10.1007/s00436-018-5991-7]
13. Layegh P, Moghiman T, Hoseini SAA. Children and cutaneous leishmaniasis: a clinical report and review. The Journal of Infection in Developing Countries. 2013;7(08):614-7. [DOI:10.3855/jidc.2939]
14. Kargar M, Hajjaran H, Moazen J, Shirzadi MR, Kazemirad E, Kalantari H, et al. Molecular identification of leishmania species in an outbreak of re-emerged cutaneous leishmaniasis in southwestern iran during 2015-2016. Archives of Clinical Infectious Diseases. 2021;16(3). [DOI:10.5812/archcid.82209]
15. Layegh P, Rahsepar S, Rahsepar AA. Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults. The American journal of tropical medicine and hygiene. 2011;84(4):539. [DOI:10.4269/ajtmh.2011.10-0002]
16. Scott P, Novais FO. Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nature Reviews Immunology. 2016;16(9):581-92. [DOI:10.1038/nri.2016.72]
17. Akbari E, Mayvaneh E, Entezari A, Nazari M. Survey of the role of bioclimatic factors in the outbreak of cutaneous leishmaniasis. 2014.
18. Al-Obaidi MJ, Abd Al-Hussein MY, Al-Saqur IM. Survey study on the prevalence of cutaneous leishmaniasis in Iraq. Iraqi Journal of Science. 2016;57(3C):2181-7.
19. Khan A, Sajid R, Gul S, Hussain A, Zehri MT, Naz S, et al. Epidemiological and pathological characteristics of Cutaneous Leishmaniasis from Baluchistan Province of Pakistan. Parasitology. 2021;148(5):591-7. [DOI:10.1017/S0031182020002413]
20. Faraj T, Lake IR. The seasonality of cutaneous leishmaniasis in Asir Region, Saudi Arabia. International Journal of Environment and Sustainability. 2015;3(3). [DOI:10.24102/ijes.v3i3.519]
21. Elyasi H, Masoudyar E, Salouri S. Epidemiology of Cutaneous Leishmaniasis in Sabzevar (Iran) From 2009-2013. Pharmacophore. 2017;8(4-2017):66-71.
22. Hashemi H, Khodabakhshi A, Sepasian M. An eco-epidemiological study of cutaneous leishmaniasis in Dezful, Iran, during 2004-2011. Journal of Occupational Health and Epidemiology. 2014;3(1):45-50. [DOI:10.18869/acadpub.johe.3.1.45]
23. Feiz-Haddad M-H, Kassiri H, Kasiri N, Panahandeh A, Lotfi M. Prevalence and epidemiologic profile of acute cutaneous leishmaniasis in an endemic focus, Southwestern Iran. Journal of Acute Disease. 2015;4(4):292-7. [DOI:10.1016/j.joad.2015.06.007]
24. Karimi T, Sharifi I, Aflatoonian MR, Aflatoonian B, Mohammadi MA, Salarkia E, et al. A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor. Parasites & Vectors. 2021;14:1-14. [DOI:10.1186/s13071-021-04619-3]
25. Hezari F, Niyyati M, Tabaei SJS, Mohebali M, Vaziri VM, Behniafar H, et al. Frequency of cutaneous leishmaniasis and species identification in suspected individuals from Golestan province, Northern Iran in 2014. Iranian journal of public health. 2016;45(10):1348.
26. Maleki M, Yousefi M, Bazzaz SMM, Tabassi SAS, Rakhshandeh H, Hamedi SS, et al. An overview of skin lesions adapted to Cutaneous Leishmaniasis in Persian Medicine. Electronic physician. 2017;9(11):5854. [DOI:10.19082/5854]
27. Khazaei S, Hafshejani AM, Saatchi M, Salehiniya H, Nematollahi S. Epidemiological aspects of cutaneous leishmaniasis in Iran. Archives of Clinical Infectious Diseases. 2015;10(3). [DOI:10.5812/archcid.28511]
28. Murback NDN, Hans Filho G, Nascimento RAFd, Nakazato KRdO, Dorval MEMC. American cutaneous leishmaniasis: clinical, epidemiological and laboratory studies conducted at a university teaching hospital in Campo Grande, Mato Grosso do Sul, Brazil. Anais brasileiros de dermatologia. 2011;86:55-63. [DOI:10.1590/S0365-05962011000100007]
29. Norouzinezhad F, Ghaffari F, Norouzinejad A, Kaveh F, Gouya MM. Cutaneous leishmaniasis in Iran: results from an epidemiological study in urban and rural provinces. Asian Pacific journal of tropical biomedicine. 2016;6(7):614-9. [DOI:10.1016/j.apjtb.2016.05.005]
30. Uzun S, Durdu M, Culha G, Allahverdiyev AM, Memisoglu HR. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey. Journal of Parasitology. 2004;90(4):853-9. [DOI:10.1645/GE-185R]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Designed & Developed by : Yektaweb